Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study To Evaluate the Efficacy and Safety of AG-348 in Regularly Transfused Adult Subjects With Pyruvate Kinase (PK) Deficiency

NCT03559699 is registered in ClinicalTrials.gov with Agios Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03559699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study To Evaluate the Efficacy and Safety of AG-348 in Regularly Transfused Adult Subjects With Pyruvate Kinase (PK) Deficiency
Lead sponsor
Agios Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 26, 2018
Completion date
November 12, 2020
Enrollment
27 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hemolytic, pyruvate kinase deficiency